Harbin Gloria Pharmaceuticals Co Ltd
002437
Company Profile
Business description
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Contact
Beijing Road No 29
Harbin Economic and Technological Development Zone
Harbin150025
CHNT: +86 1059711207
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,350
Stocks News & Analysis
stocks
Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity
Ongoing rate hikes have investors spooked.
stocks
ASX dividend champions: Stocks, ETFs and LICs
Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,879.30 | 12.90 | -0.15% |
| CAC 40 | 8,086.00 | 31.42 | -0.39% |
| DAX 40 | 24,606.77 | 130.47 | -0.53% |
| Dow JONES (US) | 50,285.66 | 276.31 | 0.55% |
| FTSE 100 | 10,443.47 | 11.13 | 0.11% |
| HKSE | 25,596.87 | 210.35 | 0.83% |
| NASDAQ | 26,293.10 | 22.74 | 0.09% |
| Nikkei 225 | 62,820.09 | 1,135.95 | 1.84% |
| NZX 50 Index | 12,923.14 | 45.07 | 0.35% |
| S&P 500 | 7,445.72 | 12.75 | 0.17% |
| S&P/ASX 200 | 8,655.90 | 16.20 | -0.19% |
| SSE Composite Index | 4,096.17 | 18.90 | 0.46% |